VRTX: Vertex Pharmaceuticals Incorporated Stock

by  •  • Comments Off on VRTX: Vertex Pharmaceuticals Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 124,633.88
Enterprise Value ($M) 118,109.38
Book Value ($M) 15,630.90
Book Value / Share 60.70
Price / Book 7.97
NCAV ($M) 3,194.80
NCAV / Share 12.41
Price / NCAV 39.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.03
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 2.20
Current Ratio 2.47

Balance Sheet (mrq) ($M)
Current Assets 9,804.10
Assets 22,240.20
Liabilities 6,609.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13G/A Capital World Investors 10.00 17.31
02-13 13G/A Vanguard Group Inc 8.65 3.41
02-09 13G/A Fmr Llc 5.04 -27.38
01-25 13G BlackRock, Inc. 8.50 -9.74

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 394,367 2,016,150 19.56
2024-11-14 92,599 767,007 12.07
2024-11-13 152,566 640,263 23.83
2024-11-12 101,854 744,205 13.69
2024-11-11 94,334 884,007 10.67

(click for more detail)

Similar Companies
VIGL – Vigil Neuroscience, Inc. VIR – Vir Biotechnology, Inc.
VOR – Vor Biopharma Inc. VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io